Christopher Butler to Doxycycline
This is a "connection" page, showing publications Christopher Butler has written about Doxycycline.
Connection Strength
0.767
-
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Respir Med. 2021 09; 9(9):1010-1020.
Score: 0.733
-
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. BMJ Open. 2017 01 23; 7(1):e013398.
Score: 0.034